Neurology, ISSN 0028-3878, 05/2006, Volume 66, Issue 10, pp. 1485 - 1489
Background: The authors previously proposed diagnostic criteria for neuromyelitis optica (NMO) that facilitate its distinction from prototypic multiple...
MULTIPLE-SCLEROSIS | MARKER | MRI | GUIDELINES | DISEASE | CSF | AQUAPORIN-4 | MECHANISMS | AUTOANTIBODY | BRAIN | CLINICAL NEUROLOGY | Antibody Specificity | Optic Nerve - pathology | Multiple Sclerosis - diagnosis | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Middle Aged | Male | Multiple Sclerosis - diagnostic imaging | Spinal Cord - pathology | Sensitivity and Specificity | Adult | Female | Fluorescent Antibody Technique, Indirect | Neuromyelitis Optica - diagnosis | Diagnosis, Differential | Aquaporin 4 - immunology | Neuromyelitis Optica - pathology | Neuromyelitis Optica - diagnostic imaging | Disease Progression | Multiple Sclerosis - classification | Radiography | Magnetic Resonance Imaging | Neuromyelitis Optica - classification | Autoantigens - immunology | Adolescent | Biomarkers | Brain - pathology | Multiple Sclerosis - pathology | Aged
MULTIPLE-SCLEROSIS | MARKER | MRI | GUIDELINES | DISEASE | CSF | AQUAPORIN-4 | MECHANISMS | AUTOANTIBODY | BRAIN | CLINICAL NEUROLOGY | Antibody Specificity | Optic Nerve - pathology | Multiple Sclerosis - diagnosis | Immunoglobulin G - blood | Autoantibodies - blood | Humans | Middle Aged | Male | Multiple Sclerosis - diagnostic imaging | Spinal Cord - pathology | Sensitivity and Specificity | Adult | Female | Fluorescent Antibody Technique, Indirect | Neuromyelitis Optica - diagnosis | Diagnosis, Differential | Aquaporin 4 - immunology | Neuromyelitis Optica - pathology | Neuromyelitis Optica - diagnostic imaging | Disease Progression | Multiple Sclerosis - classification | Radiography | Magnetic Resonance Imaging | Neuromyelitis Optica - classification | Autoantigens - immunology | Adolescent | Biomarkers | Brain - pathology | Multiple Sclerosis - pathology | Aged
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 280
Background: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein...
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | EXTENSIVE TRANSVERSE MYELITIS | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | PREGNANCY-RELATED RELAPSE | NEUROSCIENCES | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | EXTENSIVE TRANSVERSE MYELITIS | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | PREGNANCY-RELATED RELAPSE | NEUROSCIENCES | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Journal Article
Neurology, ISSN 0028-3878, 07/2017, Volume 89, Issue 3, pp. 269 - 278
OBJECTIVE: To establish whether children with relapsing acquired demyelinating syndromes (RDS) and myelin oligodendrocyte glycoprotein antibodies (MOG-Ab) show...
Aquaporin 4 | Brain | Recurrence | Autoantibodies | Encephalomyelitis | Follow-Up Studies | Humans | Child, Preschool | Myelin-Oligodendrocyte Glycoprotein | Optic Neuritis | Male | Herpesvirus 4, Human | Oligoclonal Bands | Viral Load | Journal Article | Multiple Sclerosis | Magnetic Resonance Imaging | Neuromyelitis Optica | Algorithms | Clinical Decision-Making | Adolescent | Female | Retrospective Studies | Child | CRITERIA | OPTICA SPECTRUM DISORDERS | MULTIPLE-SCLEROSIS | NEUROMYELITIS-OPTICA | CLINICAL-DIAGNOSIS | OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES | DISSEMINATED ENCEPHALOMYELITIS | THERAPEUTIC STRATEGIES | AQP4-IGG | MOG-IGG | CLINICAL NEUROLOGY | Myelin-Oligodendrocyte Glycoprotein - immunology | Brain - diagnostic imaging | Multiple Sclerosis - blood | Autoantibodies - blood | Multiple Sclerosis - diagnostic imaging | Optic Neuritis - diagnosis | Neuromyelitis Optica - immunology | Encephalomyelitis - diagnosis | Optic Neuritis - immunology | Encephalomyelitis - diagnostic imaging | Neuromyelitis Optica - diagnosis | Encephalomyelitis - blood | Aquaporin 4 - immunology | Optic Neuritis - diagnostic imaging | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Optic Neuritis - blood | Encephalomyelitis - immunology | Multiple Sclerosis - immunology
Aquaporin 4 | Brain | Recurrence | Autoantibodies | Encephalomyelitis | Follow-Up Studies | Humans | Child, Preschool | Myelin-Oligodendrocyte Glycoprotein | Optic Neuritis | Male | Herpesvirus 4, Human | Oligoclonal Bands | Viral Load | Journal Article | Multiple Sclerosis | Magnetic Resonance Imaging | Neuromyelitis Optica | Algorithms | Clinical Decision-Making | Adolescent | Female | Retrospective Studies | Child | CRITERIA | OPTICA SPECTRUM DISORDERS | MULTIPLE-SCLEROSIS | NEUROMYELITIS-OPTICA | CLINICAL-DIAGNOSIS | OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES | DISSEMINATED ENCEPHALOMYELITIS | THERAPEUTIC STRATEGIES | AQP4-IGG | MOG-IGG | CLINICAL NEUROLOGY | Myelin-Oligodendrocyte Glycoprotein - immunology | Brain - diagnostic imaging | Multiple Sclerosis - blood | Autoantibodies - blood | Multiple Sclerosis - diagnostic imaging | Optic Neuritis - diagnosis | Neuromyelitis Optica - immunology | Encephalomyelitis - diagnosis | Optic Neuritis - immunology | Encephalomyelitis - diagnostic imaging | Neuromyelitis Optica - diagnosis | Encephalomyelitis - blood | Aquaporin 4 - immunology | Optic Neuritis - diagnostic imaging | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Optic Neuritis - blood | Encephalomyelitis - immunology | Multiple Sclerosis - immunology
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 02/2018, Volume 89, Issue 2, pp. 127 - 137
ObjectiveWe characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (MOG)...
acute disseminated encephalomyelitis | myelin oligodendrocyte glycoprotein antibodies | outcomes | therapy | optic neuritis | SURGERY | MULTICENTER | PSYCHIATRY | MULTIPHASIC DISSEMINATED ENCEPHALOMYELITIS | CNS | CLINICAL NEUROLOGY | CHILDREN | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | NEUROMYELITIS-OPTICA | RITUXIMAB | DISEASE | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Brain - diagnostic imaging | Demyelinating Autoimmune Diseases, CNS - diagnostic imaging | Neuromyelitis Optica - therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Neuromyelitis Optica - immunology | Demyelinating Autoimmune Diseases, CNS - immunology | Demyelinating Autoimmune Diseases, CNS - physiopathology | Young Adult | Rituximab - therapeutic use | Immunotherapy | Myelitis, Transverse - physiopathology | Adult | Female | Child | Optic Neuritis - immunology | Myelitis, Transverse - immunology | Myelitis, Transverse - therapy | Demyelinating Autoimmune Diseases, CNS - therapy | Encephalomyelitis, Acute Disseminated - therapy | Optic Neuritis - therapy | Optic Neuritis - diagnostic imaging | Neuromyelitis Optica - physiopathology | Encephalomyelitis, Acute Disseminated - physiopathology | Myelitis, Transverse - diagnostic imaging | Neuromyelitis Optica - diagnostic imaging | Encephalomyelitis, Acute Disseminated - diagnostic imaging | Magnetic Resonance Imaging | Autoantibodies - immunology | Mycophenolic Acid - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Optic Neuritis - physiopathology | Encephalomyelitis, Acute Disseminated - immunology | Adolescent | Aged | Prednisone - therapeutic use | Cohort Studies | Immunologic Factors - therapeutic use | Care and treatment | Usage | Demyelinating diseases | Health aspects | Myelin proteins | Neurology | Multiple sclerosis | Immunoglobulins | Disease | Laboratories | Aquaporins | Software | Glycoproteins | Adults | Patients | Psychiatry | 1506 | Neuro-Inflammation
acute disseminated encephalomyelitis | myelin oligodendrocyte glycoprotein antibodies | outcomes | therapy | optic neuritis | SURGERY | MULTICENTER | PSYCHIATRY | MULTIPHASIC DISSEMINATED ENCEPHALOMYELITIS | CNS | CLINICAL NEUROLOGY | CHILDREN | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | NEUROMYELITIS-OPTICA | RITUXIMAB | DISEASE | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Brain - diagnostic imaging | Demyelinating Autoimmune Diseases, CNS - diagnostic imaging | Neuromyelitis Optica - therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Neuromyelitis Optica - immunology | Demyelinating Autoimmune Diseases, CNS - immunology | Demyelinating Autoimmune Diseases, CNS - physiopathology | Young Adult | Rituximab - therapeutic use | Immunotherapy | Myelitis, Transverse - physiopathology | Adult | Female | Child | Optic Neuritis - immunology | Myelitis, Transverse - immunology | Myelitis, Transverse - therapy | Demyelinating Autoimmune Diseases, CNS - therapy | Encephalomyelitis, Acute Disseminated - therapy | Optic Neuritis - therapy | Optic Neuritis - diagnostic imaging | Neuromyelitis Optica - physiopathology | Encephalomyelitis, Acute Disseminated - physiopathology | Myelitis, Transverse - diagnostic imaging | Neuromyelitis Optica - diagnostic imaging | Encephalomyelitis, Acute Disseminated - diagnostic imaging | Magnetic Resonance Imaging | Autoantibodies - immunology | Mycophenolic Acid - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Optic Neuritis - physiopathology | Encephalomyelitis, Acute Disseminated - immunology | Adolescent | Aged | Prednisone - therapeutic use | Cohort Studies | Immunologic Factors - therapeutic use | Care and treatment | Usage | Demyelinating diseases | Health aspects | Myelin proteins | Neurology | Multiple sclerosis | Immunoglobulins | Disease | Laboratories | Aquaporins | Software | Glycoproteins | Adults | Patients | Psychiatry | 1506 | Neuro-Inflammation
Journal Article
5.
Full Text
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome
Neurology, ISSN 0028-3878, 08/2017, Volume 89, Issue 9, pp. 900 - 908
OBJECTIVE:To assess the prognostic value of MOG antibodies (abs) in the differential diagnosis of acquired demyelinating syndromes (ADS). METHODS:Clinical...
MYELIN OLIGODENDROCYTE GLYCOPROTEIN | NMO | MULTICENTER | DISEASES | NEUROMYELITIS-OPTICA | AUTOIMMUNITY | ACUTE DISSEMINATED ENCEPHALOMYELITIS | DISTINCTION | SPECTRUM DISORDERS | PEDIATRIC MULTIPLE-SCLEROSIS | CLINICAL NEUROLOGY | Myelin-Oligodendrocyte Glycoprotein - immunology | Prognosis | Prospective Studies | Follow-Up Studies | Multiple Sclerosis - blood | Humans | Child, Preschool | Infant | Male | Multiple Sclerosis - diagnostic imaging | Neuromyelitis Optica - immunology | Oligoclonal Bands | Neuromyelitis Optica - cerebrospinal fluid | Female | Child | Biomarkers - metabolism | Encephalomyelitis, Acute Disseminated - cerebrospinal fluid | Diagnosis, Differential | Autoantibodies | Multiple Sclerosis - cerebrospinal fluid | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Myelin-Oligodendrocyte Glycoprotein - blood | Encephalomyelitis, Acute Disseminated - blood | Disease Progression | Encephalomyelitis, Acute Disseminated - diagnostic imaging | Magnetic Resonance Imaging | Encephalomyelitis, Acute Disseminated - immunology | Adolescent | Multiple Sclerosis - immunology
MYELIN OLIGODENDROCYTE GLYCOPROTEIN | NMO | MULTICENTER | DISEASES | NEUROMYELITIS-OPTICA | AUTOIMMUNITY | ACUTE DISSEMINATED ENCEPHALOMYELITIS | DISTINCTION | SPECTRUM DISORDERS | PEDIATRIC MULTIPLE-SCLEROSIS | CLINICAL NEUROLOGY | Myelin-Oligodendrocyte Glycoprotein - immunology | Prognosis | Prospective Studies | Follow-Up Studies | Multiple Sclerosis - blood | Humans | Child, Preschool | Infant | Male | Multiple Sclerosis - diagnostic imaging | Neuromyelitis Optica - immunology | Oligoclonal Bands | Neuromyelitis Optica - cerebrospinal fluid | Female | Child | Biomarkers - metabolism | Encephalomyelitis, Acute Disseminated - cerebrospinal fluid | Diagnosis, Differential | Autoantibodies | Multiple Sclerosis - cerebrospinal fluid | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Myelin-Oligodendrocyte Glycoprotein - blood | Encephalomyelitis, Acute Disseminated - blood | Disease Progression | Encephalomyelitis, Acute Disseminated - diagnostic imaging | Magnetic Resonance Imaging | Encephalomyelitis, Acute Disseminated - immunology | Adolescent | Multiple Sclerosis - immunology
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 08/2016, Volume 87, Issue 8, pp. 897 - 905
ObjectiveTo determine the frequency and clinical-radiological associations of antibodies to myelin oligodendrocyte glycoprotein (MOG) and aquaporin-4 (AQP4) in...
ENCEPHALOMYELITIS | SURGERY | PSYCHIATRY | SPECTRUM DISORDERS | IGG | NMO SPECTRUM | CHILDHOOD | CLINICAL NEUROLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | PEDIATRIC-PATIENTS | DISTINCTION | AQUAPORIN-4 | EXTENSIVE TRANSVERSE MYELITIS | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuroimaging | Autoantibodies - blood | Humans | Child, Preschool | Infant | Male | Neuromyelitis Optica - immunology | Myelitis, Transverse - cerebrospinal fluid | Aquaporin 4 - blood | Leukocytosis - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Brain Stem - pathology | Female | Child | Myelitis, Transverse - immunology | Aquaporin 4 - immunology | Oligoclonal Bands - cerebrospinal fluid | Risk Factors | Brain Stem - diagnostic imaging | Myelitis, Transverse - diagnostic imaging | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Myelin-Oligodendrocyte Glycoprotein - blood | Syndrome | Magnetic Resonance Imaging | Autoantibodies - immunology | Adolescent | Myelitis, Transverse - blood | Viral antibodies | Usage | Care and treatment | Antibodies | Neuromyelitis optica | Diagnosis | Children
ENCEPHALOMYELITIS | SURGERY | PSYCHIATRY | SPECTRUM DISORDERS | IGG | NMO SPECTRUM | CHILDHOOD | CLINICAL NEUROLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | PEDIATRIC-PATIENTS | DISTINCTION | AQUAPORIN-4 | EXTENSIVE TRANSVERSE MYELITIS | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuroimaging | Autoantibodies - blood | Humans | Child, Preschool | Infant | Male | Neuromyelitis Optica - immunology | Myelitis, Transverse - cerebrospinal fluid | Aquaporin 4 - blood | Leukocytosis - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Brain Stem - pathology | Female | Child | Myelitis, Transverse - immunology | Aquaporin 4 - immunology | Oligoclonal Bands - cerebrospinal fluid | Risk Factors | Brain Stem - diagnostic imaging | Myelitis, Transverse - diagnostic imaging | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Myelin-Oligodendrocyte Glycoprotein - blood | Syndrome | Magnetic Resonance Imaging | Autoantibodies - immunology | Adolescent | Myelitis, Transverse - blood | Viral antibodies | Usage | Care and treatment | Antibodies | Neuromyelitis optica | Diagnosis | Children
Journal Article
European Radiology, ISSN 0938-7994, 12/2016, Volume 26, Issue 12, pp. 4413 - 4422
To investigate different brain regions for grey (GM) and white matter (WM) damage in a well-defined cohort of neuromyelitis optica spectrum disorder (NMOSD)...
Diffusion tensor Imaging | Neuromyelitis optica spectrum disorder | VBM analysis | Medicine & Public Health | Diagnostic Radiology | Optical coherence tomography | Demyelination | Internal Medicine | Interventional Radiology | Imaging / Radiology | Ultrasound | Neuroradiology | ABNORMALITIES | MAGNETIZATION-TRANSFER | HUMAN CEREBRAL-CORTEX | WHITE-MATTER DAMAGE | MULTIPLE-SCLEROSIS | SPECTROSCOPY | DIFFUSION-TENSOR | DISEASE | DIAGNOSTIC-CRITERIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Optic Nerve - diagnostic imaging | Brain - diagnostic imaging | Tomography, Optical Coherence | Humans | Middle Aged | Male | Neuromyelitis Optica - diagnostic imaging | Case-Control Studies | Diffusion Tensor Imaging | Gray Matter - diagnostic imaging | Magnetic Resonance Imaging | Multimodal Imaging | White Matter - diagnostic imaging | Anisotropy | Adult | Female | Brain | Medical research | Radiation | Medicine, Experimental | Brain damage | Neuromyelitis optica
Diffusion tensor Imaging | Neuromyelitis optica spectrum disorder | VBM analysis | Medicine & Public Health | Diagnostic Radiology | Optical coherence tomography | Demyelination | Internal Medicine | Interventional Radiology | Imaging / Radiology | Ultrasound | Neuroradiology | ABNORMALITIES | MAGNETIZATION-TRANSFER | HUMAN CEREBRAL-CORTEX | WHITE-MATTER DAMAGE | MULTIPLE-SCLEROSIS | SPECTROSCOPY | DIFFUSION-TENSOR | DISEASE | DIAGNOSTIC-CRITERIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Optic Nerve - diagnostic imaging | Brain - diagnostic imaging | Tomography, Optical Coherence | Humans | Middle Aged | Male | Neuromyelitis Optica - diagnostic imaging | Case-Control Studies | Diffusion Tensor Imaging | Gray Matter - diagnostic imaging | Magnetic Resonance Imaging | Multimodal Imaging | White Matter - diagnostic imaging | Anisotropy | Adult | Female | Brain | Medical research | Radiation | Medicine, Experimental | Brain damage | Neuromyelitis optica
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 11/2016, Volume 13, Issue 1, p. 281
Background: Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis...
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Myelitis | Myelin oligodendrocyte glycoprotein (MOG) antibodies | Respiratory insufficiency | Optic neuritis | Cerebellitis | Intractable nausea and vomiting | MOG-IgG | Rhombencephalitis | Facial nerve palsy | Hearing loss | Diplopia Internuclear ophthalmoplegia (INO) | Ataxia | Neuromyelitis optica spectrum disorders (NMOSD) | Brainstem encephalitis | Longitudinally extensive transverse myelitis (LETM) | IMMUNOLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | ACUTE DISSEMINATED ENCEPHALOMYELITIS | EXTENSIVE TRANSVERSE MYELITIS | AQUAPORIN-4 ANTIBODY | INTERFERON-BETA | CLINICAL-COURSE | NEUROSCIENCES | LESIONS | OPTICA SPECTRUM DISORDERS | NEUROMYELITIS-OPTICA | DIAGNOSTIC-CRITERIA | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuromyelitis Optica - drug therapy | Age Factors | Immunoglobulin G - blood | Encephalitis - diagnostic imaging | Humans | Middle Aged | Male | Neuromyelitis Optica - immunology | Interferon-beta - therapeutic use | Young Adult | Rituximab - therapeutic use | Myelitis - immunology | Adult | Female | Disability Evaluation | Brain Stem - diagnostic imaging | Myelitis - blood | Myelitis - pathology | Encephalitis - immunology | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Blood-Brain Barrier - pathology | Magnetic Resonance Imaging | Adolescent | Brain Stem - physiopathology | Encephalitis - blood | Cohort Studies | Prevention | Immunoglobulin G | Immunotherapy | Influence | Brain damage | Research | Health aspects | Myelin proteins | Risk factors
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Myelitis | Myelin oligodendrocyte glycoprotein (MOG) antibodies | Respiratory insufficiency | Optic neuritis | Cerebellitis | Intractable nausea and vomiting | MOG-IgG | Rhombencephalitis | Facial nerve palsy | Hearing loss | Diplopia Internuclear ophthalmoplegia (INO) | Ataxia | Neuromyelitis optica spectrum disorders (NMOSD) | Brainstem encephalitis | Longitudinally extensive transverse myelitis (LETM) | IMMUNOLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | ACUTE DISSEMINATED ENCEPHALOMYELITIS | EXTENSIVE TRANSVERSE MYELITIS | AQUAPORIN-4 ANTIBODY | INTERFERON-BETA | CLINICAL-COURSE | NEUROSCIENCES | LESIONS | OPTICA SPECTRUM DISORDERS | NEUROMYELITIS-OPTICA | DIAGNOSTIC-CRITERIA | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuromyelitis Optica - drug therapy | Age Factors | Immunoglobulin G - blood | Encephalitis - diagnostic imaging | Humans | Middle Aged | Male | Neuromyelitis Optica - immunology | Interferon-beta - therapeutic use | Young Adult | Rituximab - therapeutic use | Myelitis - immunology | Adult | Female | Disability Evaluation | Brain Stem - diagnostic imaging | Myelitis - blood | Myelitis - pathology | Encephalitis - immunology | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Blood-Brain Barrier - pathology | Magnetic Resonance Imaging | Adolescent | Brain Stem - physiopathology | Encephalitis - blood | Cohort Studies | Prevention | Immunoglobulin G | Immunotherapy | Influence | Brain damage | Research | Health aspects | Myelin proteins | Risk factors
Journal Article
British Journal of Radiology, ISSN 0007-1285, 2018, Volume 91, Issue 1086, p. 20170690
Neuromyelitis optica is a neurotropic autoimmune inflammatory disease of the central nervous system traditionally thought to exclusively involve the optic...
DIAGNOSTIC-CRITERIA | MATTER DAMAGE | ABNORMALITIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Brain - diagnostic imaging | Humans | Middle Aged | Brain Stem - diagnostic imaging | Magnetic Resonance Imaging - methods | Male | Neuromyelitis Optica - diagnostic imaging | Cerebral Aqueduct - diagnostic imaging | White Matter - diagnostic imaging | Lateral Ventricles - diagnostic imaging | Cerebral Ventricles - diagnostic imaging | Pyramidal Tracts - diagnostic imaging | Adult | Female | Aged | Diencephalon - diagnostic imaging | Pictorial Review
DIAGNOSTIC-CRITERIA | MATTER DAMAGE | ABNORMALITIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Brain - diagnostic imaging | Humans | Middle Aged | Brain Stem - diagnostic imaging | Magnetic Resonance Imaging - methods | Male | Neuromyelitis Optica - diagnostic imaging | Cerebral Aqueduct - diagnostic imaging | White Matter - diagnostic imaging | Lateral Ventricles - diagnostic imaging | Cerebral Ventricles - diagnostic imaging | Pyramidal Tracts - diagnostic imaging | Adult | Female | Aged | Diencephalon - diagnostic imaging | Pictorial Review
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 8/2018, Volume 24, Issue 9, pp. 1256 - 1258
Brain MRI was originally considered to appear normal in neuromyelitis optica spectrum disorders (NMO-SD). Typical brain lesions are now well described and have...
leukodystrophy | Neuromyelitis optica | white matter disease | brain MRI | DIAGNOSTIC-CRITERIA | NEUROSCIENCES | CLINICAL NEUROLOGY | Leukoencephalopathies - pathology | Diagnosis, Differential | Humans | Leukoencephalopathies - diagnostic imaging | Middle Aged | Neuromyelitis Optica - pathology | Brain Diseases - diagnostic imaging | Neuromyelitis Optica - diagnostic imaging | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | Brain Diseases - pathology | Female | Aquaporin 4 | Neuromyelitis | Magnetic resonance imaging | Substantia alba | Leukodystrophy | Mimicry
leukodystrophy | Neuromyelitis optica | white matter disease | brain MRI | DIAGNOSTIC-CRITERIA | NEUROSCIENCES | CLINICAL NEUROLOGY | Leukoencephalopathies - pathology | Diagnosis, Differential | Humans | Leukoencephalopathies - diagnostic imaging | Middle Aged | Neuromyelitis Optica - pathology | Brain Diseases - diagnostic imaging | Neuromyelitis Optica - diagnostic imaging | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | Brain Diseases - pathology | Female | Aquaporin 4 | Neuromyelitis | Magnetic resonance imaging | Substantia alba | Leukodystrophy | Mimicry
Journal Article
Neurology, ISSN 0028-3878, 12/2016, Volume 87, Issue 23, pp. 2463 - 2470
OBJECTIVE:We tested whether brain gray matter (GM) imaging measures can differentiate between multiple sclerosis (MS) and neuromyelitis optica (NMO) using...
NMO | CLASSIFICATION ALGORITHMS | ATROPHY | MORPHOMETRY | COGNITIVE IMPAIRMENT | PATHOLOGY | DIAGNOSTIC-CRITERIA | BRAIN | LESIONS | CLINICAL NEUROLOGY | Disability Evaluation | Brain - diagnostic imaging | Diagnosis, Differential | Humans | Image Interpretation, Computer-Assisted - methods | Magnetic Resonance Imaging - methods | Organ Size | Male | Neuromyelitis Optica - diagnostic imaging | Gray Matter - diagnostic imaging | Atrophy | Neuromyelitis Optica - classification | Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - classification | Retrospective Studies
NMO | CLASSIFICATION ALGORITHMS | ATROPHY | MORPHOMETRY | COGNITIVE IMPAIRMENT | PATHOLOGY | DIAGNOSTIC-CRITERIA | BRAIN | LESIONS | CLINICAL NEUROLOGY | Disability Evaluation | Brain - diagnostic imaging | Diagnosis, Differential | Humans | Image Interpretation, Computer-Assisted - methods | Magnetic Resonance Imaging - methods | Organ Size | Male | Neuromyelitis Optica - diagnostic imaging | Gray Matter - diagnostic imaging | Atrophy | Neuromyelitis Optica - classification | Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - classification | Retrospective Studies
Journal Article